Mass Ave Global’s Pfizer PFE Stock Holding History

Mass Ave Global’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.91M	Buy	+37,345	New	+$1.79M	0.56%	26

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mass Ave Global's PFE Position: Q4 2022 in Review

Mass Ave Global opened a new position in Pfizer (PFE) in Q4 2022: 37,345 shares worth $1.91M. The stake represents 0.56% of the portfolio and ranks #26 among its holdings.

3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

Mass Ave Global held 37,345 shares of Pfizer worth $1.91M as of Q4 2022.
Pfizer was a new Mass Ave Global position in Q4 2022.
Pfizer made up 0.56% of Mass Ave Global's portfolio in Q4 2022, its #26 holding.
3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Mass Ave Global's 13F filing for Q4 2022, filed 14 Feb 2023.